Is the TAVR halo effect real? Our analysis says yes.

By Megan Tooley and Brian Contos, Cardiovascular Roundtable

For CV programs considering developing a transcatheter aortic valve replacement (TAVR) program, the anticipated "halo effect" of TAVR on the business as a whole is understandably a significant driver. This halo effect is typically the result of downstream volumes from valve screening clinics (e.g., patients deemed ineligible for TAVR receiving another procedure), upstream and downstream diagnostics required for TAVR, and new referral relationships established due to the presence of this high-end procedure and enhanced reputation.

But how substantial is this halo effect on a TAVR program’s overall valve volumes? We ran the numbers to find out.

This is a preview of restricted content.

Full access to this content is reserved for Cardiovascular Roundtable members. Log in now or learn more about Cardiovascular Roundtable.

Next, Check Out

Cardiovascular Clinical Technology Compendium

More

Join the discussion

Please log in to comment.
Close

Forgot your password?


Not an Advisory Board Member? Click here to register

Close

Members please Log In

LOG IN

Forgot your password?


Not an Advisory Board Member? Click here to register